written on 25.06.2014
Tags:
,

J&J, GSK meds join Sovaldi, Tecfidera in blockbuster-to-be crowd

TAGS: ,

New drug approvals may have dropped from 2012's high of 43 to 35 last year. But that doesn't mean 2013's crop lacks superstars.

Latest Report